Formosa Pharmaceuticals, Inc. (TPE:6838)

Formosa Pharmaceuticals Revenue

Formosa Pharmaceuticals had revenue of 3.03M TWD in the quarter ending June 30, 2026, a decrease of -36.48%. This brings the company's total for the last twelve months to 52.59M, up 237.39% year-over-year. In the year 2025, Formosa Pharmaceuticals had annual revenue of 9.50M, down -93.38%. That makes Formosa Pharmaceuticals the 42,773rd largest company in the world by revenue and 2,144th in Taiwan.

• Revenue (ttm): 52.59M
• Revenue Growth: +237.39%
• P/S Ratio: 72.64
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.82B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• America 4.76M 50.2%
• Asia 4.73M 49.8%

Fiscal year ended Dec 31, 2025 See the full Formosa Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.50M	-133.86M	-93.38%
Dec 31, 2024	143.36M	112.18M	359.89%
Dec 31, 2023	31.17M	29.86M	2,270.49%
Dec 31, 2022	1.32M	-27.21M	-95.39%
Dec 31, 2021	28.53M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error